Literature DB >> 29528811

Excess EDTA interferes with cortisol measurement using a solid-phase, chemiluminescent enzyme immunoassay.

Robert J Kemppainen1, Ellen N Behrend1, Stephanie F Carter1, Janeva E Cole1.   

Abstract

Hormone assays that use a solid-phase, automated, chemiluminescent enzyme immunoassay (CEIA) with an alkaline phosphatase-tagged hormone or antibody as a reporter are performed on serum or EDTA plasma in our laboratory. CEIA cortisol results appeared to increase in the presence of excess EDTA. We investigated the effect of the addition of different amounts of EDTA on cortisol concentrations in pooled canine serum samples. The recommended EDTA plasma concentration of 4.1 mmol/L (1.8 mg/mL) did not alter cortisol concentrations when added to serum pools; however, the addition of ≥5.1 mmol/L (2.25 mg/mL) of EDTA increased apparent concentrations of cortisol. Supplementation of serum samples with MgCl2 to 5 mmol/L reversed the effect of EDTA up to a concentration of ~8.1 mmol/L (3.6 mg/mL). Our findings show that CEIA cortisol results on EDTA plasma can be artificially increased if the EDTA concentration exceeds 5.1 mmol/L.

Entities:  

Keywords:  Alkaline phosphatase; EDTA; assay interference; chemiluminescent immunoassay; cortisol; magnesium

Mesh:

Substances:

Year:  2018        PMID: 29528811      PMCID: PMC6505827          DOI: 10.1177/1040638718763474

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

1.  Comparison of steroid and thyroid hormone concentrations in blood serum and plasma of captive tigers.

Authors:  Kellie A Fecteau; Luca Giori; Andrew Cushing; Joshua M Price; Xiaojuan Zhu
Journal:  J Vet Diagn Invest       Date:  2022-04-11       Impact factor: 1.569

2.  Effect of EDTA on measurement of cortisol and thyroxine by chemiluminescent enzyme immunoassay in dogs.

Authors:  Dana A Schechter; Hollie P Lee; Robert J Kemppainen; Ellen N Behrend
Journal:  J Vet Diagn Invest       Date:  2020-04-02       Impact factor: 1.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.